FDx Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

FDx Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,632	Closed	-$256K	–	668
2020 Q2	$256K	Buy	+2,632	New	+$245K	0.01%	475
2018 Q1	–	Sell	-3,594	Closed	-$327K	–	1289
2017 Q4	$327K	Sell	3,594 -80	-2%	-$6.66K	0.01%	990
2017 Q3	$280K	Sell	3,674 -80	-2%	-$6.05K	0.01%	1069
2017 Q2	$282K	Sell	3,754 -97	-3%	-$6.72K	0.01%	1009
2017 Q1	$251K	Buy	+3,851	New	+$227K	0.01%	1032
2016 Q3	–	Sell	-5,154	Closed	-$215K	–	968
2016 Q2	$215K	Buy	5,154 +305	+6%	+$14.1K	0.01%	821
2016 Q1	$207K	Buy	+4,849	New	+$205K	0.01%	843

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

FDx Advisors's PRAH Position: Q3 2020 in Review

FDx Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 2,632 shares — an estimated $256K sold.

FDx Advisors first reported a position in PRAH in Q1 2016 and held it in 7 quarters. The position peaked at $327K in Q4 2017. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

FDx Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
FDx Advisors sold 2,632 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $256K.
FDx Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 7 quarters.
FDx Advisors's PRA Health Sciences, Inc. position peaked at $327K in Q4 2017.
281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on FDx Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.